An observational study in Hip Arthroplasty Replacement, sponsored by Copenhagen University Hospital, Hvidovre. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-21.
Sponsored by Copenhagen University Hospital, Hvidovre · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Hemorrhage with a site in Denmark — 6 open to participants now, 9 under way, 2 of them phase 3. Hemorrhage · Denmark.
Among the 38 studies in Hemorrhage with a site in Denmark, this one is the 10th largest by planned enrollment of the 12 observational ones that give a count, is one of 2 that started in 2025, is one of 14 observational ones, and was the 36th registered.
1,384 studies on the registry are indexed under Hemorrhage; 245 are open to participants now.
Browse Hemorrhage studies →6 of the 38 studies in Hemorrhage with a site in Denmark are open now. Recruiting first, the newest first:
University of Aarhus · Sites in Denmark
Ages 75+
Nordsjaellands Hospital · Sites in Denmark
Ages 2+
Pfizer · Sites in Denmark, United States, Argentina and 19 more countries
Ages 1–17 · Men only
Population Health Research Institute · Sites in Denmark, Belgium, Botswana and 15 more countries
Ages 18+
Rigshospitalet, Denmark · Sites in Denmark
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 171 Hemorrhage studies recruiting now, 109 (64%) set no upper age limit and 41 (24%) stop at 75 or younger; 26 take children under 18; 21 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 25 is below the median of 215 across 397 observational studies indexed under Hemorrhage.
Median enrollment 161 across the 24 interventional studies, 88 across the 12 observational. Of the 25 that completed or were terminated, 3 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 38 have an industry lead sponsor. The 10 most frequent:
Copenhagen University Hospital, Hvidovre is the lead sponsor of 79 studies on the registry; 19 are open to participants now.
Copenhagen University Hospital, Hvidovre has 1 study filed under Hemorrhage — fewer than ten, so there is no comparison to draw.
2 of the studies in Hemorrhage with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06888908Copenhagen University Hospital, HvidovreChanges in Perioperative Blood Volume and Fluid Distribution in Patients Undergoing Primary Total Hip Replacement. | 2026-12 |
| NCT06938789University of AarhusHow Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 38 studies in Hemorrhage with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Clinical assessment of bleeding and calculation of perioperative blood loss do not provide an accurate estimate of blood volume. This makes rational fluid management difficult, which is of high importance for patient-related outcomes. The availability of carbon monoxide(CO)-rebreathing allows for simple, non-invasive and precise measurement of changes in blood volume.
The purpose of the study is to investigate and describe changes in blood volume and fluid distribution perioperative in patients undergoing total hip arthroplasty. Furthermore, to investigate the association between changes in blood volume and incidence of orthostatic insufficiency.
Patients scheduled for an elective total hip arthoplasty (THA) at Hvidovre University Hospital and undergo the proceduce under spinal anesthesia with propofol sedation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Change in total blood volume (TBV)
Measured in milliliter (mL)
Time frame: Preoperatively and 6 hours postoperatively
Change in total blood volume (TBV)
measured in mL
Time frame: Preoperatively and 24 hours postoperatively
Changes in total hemoglobin mass (tHgb)
Measured in gram (g)
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Changes in erythrocyte volume (EBV)
Measured in mL
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Changes in plasma volume (PV)
Measured in mL
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Changes in hematokrit (Ht)
Reported as percentage(%)
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Changes in hemoglobin (Hg) concentration
Measured in millimoles/liter(mmol/L)
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Changes in Total body water(TBW), intra-(ICF) and extracellular(ECF) fluid distribution
Full body water via bioelectrical impedance analysis. The individual components are reported in L and percent.
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Changes in C-Reactive Protein (CRP)
Measured in milligram/liter (mg/L)
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Incidence of orthostatic intolerance during mobilization
Symptoms of orthostatic intolerance: dizziness, nausea, vomiting, blurry vision or syncope during mobilization
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Association between total blood loss and incidence of orthostatic intolerance
Blood loss measured in mL. Symptoms of orthostatic intolerance: dizziness, nausea, vomiting, blurry vision or syncope during mobilization
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Association between changes in C-Reactive Protein and total blood loss
C-Reactive Protein measured in mg/L and total blood loss measured in mL
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Association between peripheral perfusion index and total blood loss
Peripheral perfusion index measured in percent and total blood loss in mL
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Association between total hemoglobin (SpHb) and total blood loss
SpHb measured as gram/deciliter and total blood loss measured in mL
Time frame: Preoperatively, 6 hours postoperatively and 24 hours postoperatively
Intraoperativ estimation of bleeding
Measured by weighting gauze (gram)
Time frame: Intraoperative at end of the surgical procedure
Intraoperative bleeding
Measured by visual estimation in surgical drains (mL)
Time frame: Intraoperative at end of the surgical procedure
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Mar 2025; primary completion for Sep 2026, 18 months later.
Of 134 non-industry observational studies under Hemorrhage, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 78. This study's planned 18 months is below that.
Counting every sponsor, half of 158 studies reached it within 33 months; a quarter within 15 and three quarters within 74.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Copenhagen University Hospital, Hvidovre